Form 4 for AKBA Akebia Therapeutics, Inc.
Accepted 2022-06-07 00:00:00 ET · period of report 2022-06-03 · accession 0001562180-22-004870 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-07 | 2022-06-03 | AKBA | GILMAN STEVEN C | Dir | S - Sale | $0.36 | -4,567 | 43.4K | -10% | -$1,644 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-03 | S | D | 4,567 | $0.36 | 43,430 | D | — | — |